LIVE Webinar
Thursday, October 28, 2021
2:30 - 3:30 PM Eastern Time
As scientists search for new drug targets and screen for compounds to treat disease, they often run into roadblocks related to data quality. Researchers must use their expertise to circumvent these problems if they hope to rapidly develop high-quality, novel therapeutics. In this webinar sponsored by Thermo Fisher Scientific, Drew Adams will discuss his work identifying new targets and screening small molecules to develop therapeutics for neurological diseases, with an emphasis on resolving data quality problems.
Topics to be covered
- Data quality in high-throughput screening and target validation
- Validating new targets and small molecules targeting cholesterol biosynthesis to promote remyelination
Meet the Speaker:
Drew Adams, PhD
Thomas F. Peterson Professor of Novel Therapeutics
Associate Professor, Genetics and Genome Sciences
Director, Small Molecule Drug Development Core
Case Western Reserve University School of Medicine
Sponsored By
